Biopharma Buzz: Key Updates in Pharma and Biotech
Listen now
Description
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Today's episode covers a range of key topics in the biopharma industry. First, ten-year survival data has revealed the long-term benefits of immunotherapy in melanoma, offering hope for potential cures. Kyverna has announced a CEO swap, appointing Kite veterans to lead the company's next chapter. Sanofi is gearing up to meet the US demand for an RSV antibody as the s...
More Episodes
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Merck has committed up to $3 billion in a deal with Lanova Medicines focused on PD-1/VEGF. The deal comes as Merck faces competition from Bristol Myers Squibb in...
Published 11/15/24
Published 11/15/24
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Amgen's obesity candidate, maritide, faced new safety concerns related to bone density, causing a drop in the company's stock. Biogen's shares have also plummeted due to...
Published 11/14/24